We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+0.74%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$35.6B
AUM Growth
+$166M
Cap. Flow
+$350M
Cap. Flow %
0.98%
Top 10 Hldgs %
19.85%
Holding
1,363
New
118
Increased
473
Reduced
442
Closed
143

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$76.2M
2
SPGI icon
S&P Global
SPGI
+$73M
3
ADBE icon
Adobe
ADBE
+$62.1M
4
BMY icon
Bristol-Myers Squibb
BMY
+$56.5M
5
NVDA icon
NVIDIA
NVDA
+$52.5M

Top Sells

Rank Stock Value
1
BNY
Bank of New York Mellon
BNY
+$60.1M
2
CL icon
Colgate-Palmolive
CL
+$57.1M
3
CSCO icon
Cisco
CSCO
+$55.2M
4
GNRC icon
Generac Holdings
GNRC
+$44.8M
5
BABA icon
Alibaba
BABA
+$42.1M

Sector Composition

Rank Sector Weight
1 Technology 30.84%
2 Healthcare 17.62%
3 Consumer Discretionary 11.77%
4 Financials 10.38%
5 Industrials 7.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BR icon
326
Broadridge
BR
$18.4B
$20.9M 0.06%
125,153
-16,373
-12% -$2.79M
NTR icon
327
Nutrien
NTR
$33.9B
$20.7M 0.06%
319,473
+61,098
+24% +$3.74M
PEN icon
328
Penumbra
PEN
$12.6B
$20.6M 0.06%
77,370
-130
-0.2% -$34.9K
NUVA
329
DELISTED
NuVasive, Inc.
NUVA
$20.6M 0.06%
343,438
+7,765
+2% +$479K
GIB icon
330
CGI
GIB
$15.6B
$20.5M 0.06%
241,948
-34,208
-12% -$3.08M
GNRC icon
331
Generac Holdings
GNRC
$11.5B
$20.5M 0.06%
50,139
-104,518
-68% -$44.8M
LNC icon
332
Lincoln National
LNC
$7.92B
$20.3M 0.06%
295,603
+185,000
+167% +$12.1M
CTAS icon
333
Cintas
CTAS
$86.6B
$20.2M 0.06%
212,148
-708
-0.3% -$69.3K
CXM icon
334
Sprinklr
CXM
$1.51B
$19.9M 0.06%
1,139,798
+39,798
+4% +$742K
NLSN
335
DELISTED
Nielsen Holdings plc
NLSN
$19.9M 0.06%
1,036,600
+36,100
+4% +$804K
FOUR icon
336
Shift4
FOUR
$4.45B
$19.9M 0.06%
256,096
+18,967
+8% +$1.64M
CHRW icon
337
C.H. Robinson
CHRW
$20.5B
$19.8M 0.06%
227,756
+28,488
+14% +$2.58M
RARE icon
338
Ultragenyx Pharmaceutical
RARE
$2.46B
$19.7M 0.06%
218,713
+29,735
+16% +$2.69M
LH icon
339
Labcorp
LH
$25.2B
$19.7M 0.06%
81,288
+33,751
+71% +$8.51M
URI icon
340
United Rentals
URI
$65.7B
$19.4M 0.05%
55,310
-3,472
-6% -$1.17M
INSM icon
341
Insmed
INSM
$22.4B
$19.3M 0.05%
700,200
+71,772
+11% +$1.88M
DOC
342
DELISTED
PHYSICIANS REALTY TRUST
DOC
$19.3M 0.05%
1,094,197
-546,689
-33% -$10.1M
RHI icon
343
Robert Half
RHI
$4.11B
$19.1M 0.05%
+190,100
New +$18.6M
NTES icon
344
NetEase
NTES
$83B
$19M 0.05%
222,407
-9,100
-4% -$859K
ICLR icon
345
Icon
ICLR
$13.7B
$19M 0.05%
72,466
+22,685
+46% +$5.51M
DEI icon
346
Douglas Emmett
DEI
$2.05B
$19M 0.05%
599,608
-28,432
-5% -$936K
KLAC icon
347
KLA
KLAC
$222B
$18.7M 0.05%
559,940
-14,500
-3% -$484K
NSC icon
348
Norfolk Southern
NSC
$75.4B
$18.7M 0.05%
78,291
+15,879
+25% +$4.07M
STOR
349
DELISTED
STORE Capital Corporation
STOR
$18.6M 0.05%
581,885
-108,459
-16% -$3.84M
AON icon
350
Aon
AON
$80.6B
$18.5M 0.05%
64,647
-11,300
-15% -$3.04M

Similar funds

Axa's Q3 2021 Portfolio in Review

As of Q3 2021, Axa held 1,363 positions worth $35.6B, up 0.47% from $35.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Axa's Q3 2021 filing shows 118 new, 473 increased, 442 reduced and 143 closed positions. Its largest new stake was GXO Logistics: 575,960 shares worth $45.2M. The largest sale was Bank of New York Mellon, an estimated $60.1M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q3 2021 buy was GXO Logistics: 575,960 shares worth $45.2M.
  • Axa added most to AT&T in Q3 2021, an estimated $76.2M increase.
  • Axa's biggest Q3 2021 reduction was Bank of New York Mellon, cutting an estimated $60.1M.
  • Axa fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $35.3M.
  • Axa's ten largest holdings make up 20% of its $35.6B portfolio in Q3 2021.
  • Axa opened 118 new positions and closed 143 in Q3 2021.
  • Axa's portfolio value rose 0.47% quarter-over-quarter to $35.6B.

Based on Axa's 13F filing for Q3 2021, filed 15 Nov 2021.